Forma Therapeutics Holdings Inc

NASDAQ:FMTX  
27.88
+0.22 (+0.80%)
4:00:00 PM EDT: $27.94 +0.06 (+0.22%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Forma Therapeutics Holdings, Inc. Stock, NASDAQ:FMTX

500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.679.1970
Number of Employees:

Description

Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.